89 related articles for article (PubMed ID: 32256827)
1. Semaphorin-4C is upregulated in epithelial ovarian cancer.
Huang S; Han S; Zhang J; Zhong Z; Wang J
Oncol Lett; 2020 Apr; 19(4):3333-3338. PubMed ID: 32256827
[TBL] [Abstract][Full Text] [Related]
2. Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.
Wang Y; Qiao L; Yang J; Li X; Duan Y; Liu J; Chen S; Li H; Liu D; Fang T; Ma J; Li X; Ye F; Wan J; Wei J; Xu Q; Guo E; Jin P; Wu M; Zhang L; Xia Y; Wu Y; Shao J; Feng Y; Zhang Q; Yang Z; Chen G; Zhang Q; Li X; Wang S; Hu J; Wang X; Tan MP; Takabe K; Kong B; Yang Q; Ma D; Gao Q
Cancer Commun (Lond); 2021 Dec; 41(12):1373-1386. PubMed ID: 34738326
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 4C: A Novel Component of B-Cell Polarization in Th2-Driven Immune Responses.
Xue D; Desjardins M; Kaufman GN; Béland M; Al-Tamemi S; Ahmed E; Tao S; Friedel RH; Mourad W; Mazer BD
Front Immunol; 2016; 7():558. PubMed ID: 28003812
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin 4C regulates ovarian steroidogenesis through RHOA/ROCK1-mediated actin cytoskeleton rearrangement.
Chen D; Wu C; Wei S; Guo Y; Wu M; Zhou S; Fu F; Tang W; Xue L; Zhang J; Li Y; Dai J; Li Y; Ye S; Wang S
Mol Hum Reprod; 2023 Apr; 29(5):. PubMed ID: 36892447
[TBL] [Abstract][Full Text] [Related]
5. Sema4C modulates the migration of primary tumor-associated lymphatic endothelial cells via an ERK-mediated pathway.
Peng J; Liu X; Li C; Gao M; Wang H
Exp Ther Med; 2021 Oct; 22(4):1102. PubMed ID: 34504556
[TBL] [Abstract][Full Text] [Related]
6. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
7. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
8. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
10. Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1.
Hung YH; Lai MD; Hung WC; Chen LT
Am J Cancer Res; 2022; 12(2):713-728. PubMed ID: 35261797
[TBL] [Abstract][Full Text] [Related]
11. Increased HE4 mRNA Expression Correlates with High Level Of eIF3a mRNA And Better Survival in Women with Epithelial Ovarian Cancer.
Luo CH; Zhao M; Tang YX; Shahabi S; Fang KN; Chen Y; Tang Y; Chen XY; Wang J; Zhou HH
J Cancer; 2018; 9(6):1088-1095. PubMed ID: 29581788
[TBL] [Abstract][Full Text] [Related]
12. Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.
Gurrapu S; Pupo E; Franzolin G; Lanzetti L; Tamagnone L
Cell Death Differ; 2018 Jul; 25(7):1259-1275. PubMed ID: 29555978
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and prognostic value of Forkhead box A1 expression in human epithelial ovarian cancer.
Wang K; Guan C; Fang C; Jin X; Yu J; Zhang Y; Zheng L
Oncol Lett; 2018 Apr; 15(4):4457-4462. PubMed ID: 29541214
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer.
Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH
BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759
[TBL] [Abstract][Full Text] [Related]
15. Activated matrix metalloproteinase-2--a potential marker of prognosis for epithelial ovarian cancer.
Wu X; Li H; Kang L; Li L; Wang W; Shan B
Gynecol Oncol; 2002 Jan; 84(1):126-34. PubMed ID: 11748988
[TBL] [Abstract][Full Text] [Related]
16. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
17. Discrepant clinicopathologic characteristics and HE4 performance in type I and type II epithelial ovarian cancer.
Jiang J; Bo D; Chang X; Cheng H; Ye X; Cui H
Int J Clin Exp Med; 2015; 8(11):21303-10. PubMed ID: 26885070
[TBL] [Abstract][Full Text] [Related]
18. Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells.
Zhou Q; Yu Y
Med Sci Monit; 2015 Nov; 21():3409-14. PubMed ID: 26546806
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
